Vaxcyte (PCVX) Reiterated at Overweight by Cantor Fitzgerald Afters OPUS-1 Top Line
Tweet Send to a Friend
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating and $120.00 price target on Vaxcyte (NASDAQ: PCVX).The analyst commented, "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




